Clinical Trial Update: Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating tarlatamab as maintenance therapy after chemo-radiotherapy in patients with limited-stage small cell lung cancer, and the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limited-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• Tarlatamab

Snippet

Sponsor: Fundación GECP | Conditions: Limited-stage Small-cell Lung Cancer, Carcinoma, Small Cell Lung | Phase 2 | Status: RECRUITING